Cargando…

PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8(+) T-cell activity

PI3K inhibitors with differential selectivity to distinct PI3K isoforms have been tested extensively in clinical trials, largely to target tumor epithelial cells. PI3K signaling also regulates the immune system and inhibition of PI3Kδ modulate the tumor immune microenvironment of pre-clinical mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carnevalli, Larissa S., Sinclair, Charles, Taylor, Molly A., Gutierrez, Pablo Morentin, Langdon, Sophie, Coenen-Stass, Anna M. L., Mooney, Lorraine, Hughes, Adina, Jarvis, Laura, Staniszewska, Anna, Crafter, Claire, Sidders, Ben, Hardaker, Elizabeth, Hudson, Kevin, Barry, Simon T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307194/ https://www.ncbi.nlm.nih.gov/pubmed/30587236 http://dx.doi.org/10.1186/s40425-018-0457-0

Ejemplares similares

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery
por: Taylor, Molly A., et al.
Publicado: (2019)

Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity
por: Langdon, Sophie, et al.
Publicado: (2018)

A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability
por: Kuczynski, Elizabeth A, et al.
Publicado: (2022)

Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer
por: Avivar-Valderas, Alvaro, et al.
Publicado: (2018)

Longitudinal tracking of T cell lymphomas in mice using flow cytometry
por: Kuczynski, Elizabeth A., et al.
Publicado: (2023)

Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment
por: Carnevalli, Larissa S., et al.
Publicado: (2021)

Assessment of RT-qPCR Normalization Strategies for Accurate Quantification of Extracellular microRNAs in Murine Serum
por: Roberts, Thomas C., et al.
Publicado: (2014)

BIM and NOXA are mitochondrial effectors of TAF6δ-driven apoptosis
por: Delannoy, Aurélie, et al.
Publicado: (2018)

A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
por: Karp, Natasha A., et al.
Publicado: (2020)

Detection and quantification of extracellular microRNAs in murine biofluids
por: Roberts, Thomas C, et al.
Publicado: (2014)

Repertoire Development and the Control of Cytotoxic/Effector Function in Human γ δ T Cells
por: Urban, Elizabeth M., et al.
Publicado: (2010)

Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen
por: Lynch, James T., et al.
Publicado: (2016)

PI3Kδ Forms Distinct Multiprotein Complexes at the TCR Signalosome in Naïve and Differentiated CD4(+) T Cells
por: Luff, Daisy H., et al.
Publicado: (2021)

PI3Kδ coordinates transcriptional, chromatin, and metabolic changes to promote effector CD8(+) T cells at the expense of central memory
por: Cannons, Jennifer L., et al.
Publicado: (2021)

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions
por: Cimini, Eleonora, et al.
Publicado: (2015)

The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo
por: Palazzo, Adam, et al.
Publicado: (2018)

Evaluation of methodologies for microRNA biomarker detection by next generation sequencing
por: Coenen-Stass, Anna M.L., et al.
Publicado: (2018)

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
por: Rao, V. Koneti, et al.
Publicado: (2023)

Synthetic lethality prediction in DNA damage repair, chromatin remodeling and the cell cycle using multi-omics data from cell lines and patients.
por: Markowska, Magda, et al.
Publicado: (2023)

Differentiation of Effector/Memory Vδ2 T Cells and Migratory Routes in Lymph Nodes or Inflammatory Sites
por: Dieli, Francesco, et al.
Publicado: (2003)

Effector Vγ9Vδ2 T cell response to congenital Toxoplasma gondii infection
por: Ma, Ling, et al.
Publicado: (2021)

Exhausted intratumoral Vδ2(−) γδ T cells in human kidney cancer retain effector function
por: Rancan, Chiara, et al.
Publicado: (2023)

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
por: Revenko, Alexey, et al.
Publicado: (2022)

Generation of effector Vγ9Vδ2 T cells and evaluation of their response to phosphoantigen-loaded cells
por: Hsiao, Chia-Hung Christine, et al.
Publicado: (2022)

Vaccinating for natural killer cell effector functions
por: Wagstaffe, Helen R, et al.
Publicado: (2018)

LasΔ5315 Effector Induces Extreme Starch Accumulation and Chlorosis as Ca. Liberibacter asiaticus Infection in Nicotiana benthamiana
por: Pitino, Marco, et al.
Publicado: (2018)

Discovery of Novel PI3Kδ Inhibitors Based on the p110δ Crystal Structure
por: Jia, Wenqing, et al.
Publicado: (2022)

Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics
por: Coenen-Stass, Anna M. L., et al.
Publicado: (2019)

Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD
por: Hanson, Britt, et al.
Publicado: (2022)

Obesity-Induced Metabolic Stress Leads to Biased Effector Memory CD4(+) T Cell Differentiation via PI3K p110δ-Akt-Mediated Signals
por: Mauro, Claudio, et al.
Publicado: (2017)

PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8(+) T cell-dependent antitumor immunity and abscopal effect after local irradiation
por: Yoon, Yi Na, et al.
Publicado: (2022)

Platform economy: (dis-) embeddedness processes in urban spaces
por: Hardaker, Sina
Publicado: (2021)

Beyond differential expression: the quest for causal mutations and effector molecules
por: Hudson, Nicholas J, et al.
Publicado: (2012)

Hyper-activated PI3K-δ in immunodeficiency
por: Heurtier, Lucie, et al.
Publicado: (2015)

The Treatment of Activated PI3Kδ Syndrome
por: Coulter, Tanya I., et al.
Publicado: (2018)

PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19
por: Palma, Giuseppe, et al.
Publicado: (2020)

A Review of Phosphocreatine 3 Kinase δ Subtype (PI3Kδ) and Its Inhibitors in Malignancy
por: Xiang, Qiong, et al.
Publicado: (2021)

Neuropsychological Functions of μ- and δ-Opioid Systems
por: Polunina, Anna G., et al.
Publicado: (2013)

Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates
por: Shen, Ling, et al.
Publicado: (2019)

Programación de granjas con computadoras /
por: Hardaker, J. B.
Publicado: (1975)

Cannot write session to /tmp/vufind_sessions/sess_ghshklpp1ntpvvh0iv2v29krnn